1047.8500 14.05 (1.36%)
NSE Sep 18, 2025 15:31 PM
Volume: 977.2K
 

1047.85
1.36%
Sharekhan
Healthcare (Cadila) reported 14.8% growth in total operating revenue to Rs. 3,732.8 crore (above estimate due to consolidation of the acquired business of Heinz India Pvt. Ltd. for two months). Operating profit declined by 8% to Rs. 800.4 crore (5% below estimate) and OPM declined by 533.8 BPS to 21.4% (estimated 23.2%). Adjusted profit declined by 19.5% to Rs. 479.2 crore (8.5% below...
Zydus Lifesciences L.. has an average target of 1045.33 from 6 brokers.
More from Zydus Lifesciences Ltd.
Recommended